This site uses cookies to provide user functionality. Read More.
Acknowledge

Company News

World Parkinson’s Day: Keeping the spotlight on past and future drug development, and the importance of Patient and Caregiver Engagement

By: Sondra Simpson, Project Manager, MedSource April 11th is World Parkinson’s Day. This is a day set aside to center public attention on the more than 10 million worldwide who are living with this disease. Each year approximately 60,000 Americans are diagnosed with Parkinson’s disease (PD), and it is estimated that by the year 2020, […]

Read More

MedSource Launches Staffing Solutions Division Providing Clinical, Technical, and Executive Professionals to Life Science Organizations

HOUSTON (March 11, 2019) – Houston-based MedSource continues to expand with the offering of a new business unit; MedSource Staffing Solutions. With a track record of success spanning over 20 years, the complimentary sourcing division of MedSource will continue the dedication to drug development by providing clinical, technical, and executive professionals to Life Science organizations. MedSource’s […]

Read More

Rare Disease Day 2019

Did you know that there are more than 7,000 rare diseases known to date? Defined by Congress under the Orphan Drug Act of 1983, the definition of rare disease in the United States is a condition that affects fewer than 200,000 people. In Europe, rare disease is defined as affecting fewer than 1 in 2000 […]

Read More

World Cancer Day 2019

Cancer may have started the fight, but it’s time we finish it. Every one of us knows of a family member, friend, or colleague who has been affected, or we may have been personally affected by cancer. Our goal at MedSource is bigger than one person, or one even company. Our goal is to help save […]

Read More

An Overview of Cervical Cancer History for Cervical Cancer Awareness Month

In 2019, approximately 13,170 new cases of invasive cervical cancer will be diagnosed. From these cases, nearly 4,300 women will die from the disease. Once the most common cause of cancer death for American women, cervical cancer now ranks 14th in frequency due to the increased use of the Pap test. Most cases of cervical […]

Read More

A Personalized Approach: unique strategies and data mining for small biotech companies

Within the highly competitive climate of drug development, a creative, strategic and data-driven clinical development plan is essential for navigating the clinical trial landscape. When attempting to deliver a program quickly and effectively, it can be easy to miss opportunities with limited resources, infrastructure, and technological challenges. It is imperative that a clinical research partner […]

Read More

MedSource Recognized in Top 15 Private Life Science Companies

Solid growth and expansion for Houston-based CRO furthers drug development for small & mid-sized biotech HOUSTON (October 25, 2018) – The accelerating growth track of Houston-based MedSource was recognized again recently when Biospace named the company as the # 4 fastest growing private life science company in the United States. The Biospace ranking was determined […]

Read More

5 Facts to Know about Childhood Cancer For Childhood Cancer Awareness Month

Each year, approximately 300,000 new cases of cancer affect children under the age of 19 worldwide. More than 15,000 of these children are located in the United States alone. Despite the statistics, pediatric cancer researchers and doctors continue to face challenges. Only three new drugs have been approved by the FDA specifically developed to treat […]

Read More

Sophisticated Clinical Trials for Challenging Therapeutic Areas

Clinical trials are a cornerstone in the goal of curing, managing, or even eradicating the illnesses and conditions that millions of people face every day.  In this particular trial, outlined in our latest case study, we worked with a very rare and complicated patient population.  Due to the complexity and potential complications that patients with […]

Read More

Connect

Follow us on the social media platforms below.